Discover trends, market shifts, and competitive outlooks for the digital biomarkers industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Digital Biomarkers Market From 2025 To 2029?

In recent years, the digital biomarkers market has seen significant exponential growth. It is projected to expand from a value of $3.92 billion in 2024 to $4.96 billion in 2025, symbolizing a compound annual growth rate (CAGR) of 26.3%. The robust growth during the historic period is tied to multiple factors including, the surge in mobile health applications, early adoption during clinical trials, an increase in chronic diseases, heightened consumer interest in fitness and wellness, as well as the ongoing digitalization of healthcare.

The size of the digital biomarkers market is predicted to witness substantial expansion in the coming years, soaring to $12.52 billion in 2029 with a compound annual growth rate (CAGR) of 26.1%. The surge during the forecast period can be credited to its growing acceptance by healthcare providers, an increase in chronic illness prevalence, heightened consumer consciousness, and a boosted interest in fitness and lifestyle tracking. Key tendencies during this period incorporate progress in wearable tech, incorporation with artificial intelligence, alliances and partnerships, growth in developing markets, and synthesis with electronic health records.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19397&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Digital Biomarkers Market?

The digital biomarkers market stands to benefit from the increased presence of chronic diseases. Chronic illnesses are long-lasting health issues that usually develop over time and may linger throughout a person’s life. The risk of developing chronic diseases increases with age-related conditions like osteoarthritis, Alzheimer’s disease, and heart disease, high processed food intake, and lesser physical activity. Digital biomarkers prove to be beneficial in chronic disease management, providing real-time monitoring of health parameters and disease evolution, facilitating more personalized and timely interventions. For example, in May 2023, the Centers for Disease Control and Prevention (CDC.gov), a government institution based in the US, reported that heart disease and cancer deaths counted to 6,95,547 in 2022, marking an upswing from 6,05,213 in 2021. Hence, the amplified presence of chronic diseases is likely to spur growth in the digital biomarker market.

Which Key Market Segments Comprise the Digital Biomarkers Market and Drive Its Revenue Growth?

The digital biomarkersmarket covered in this report is segmented –

1) By Type: Wearable, Mobile Based Applications, Sensors, Other Types

2) By Clinical Practice: Diagnostic Digital Biomarkers, Monitoring Digital Biomarkers, Predictive And Prognostic Digital Biomarkers, Other Clinical Practices

3) By Application: Oncology, Metabolic Disease, Neurological Disease, Cardiac Disease, Other Applications

4) By End User: Healthcare Companies, Healthcare Providers, Payers, Other End Users

Subsegments:

1) By Wearable: Smartwatches, Fitness Trackers, Wearable ECG Monitors, Continuous Glucose Monitors

2) By Mobile Based Applications: Health Monitoring Apps, Digital Therapeutics Apps, Symptom Tracking Apps, Remote Patient Monitoring Apps

3) By Sensors: Biosensors, Motion Sensors, Environmental Sensors, Implantable Sensors

4) By Other Types: Voice Biomarkers, Digital Imaging Biomarkers, Behavioral Biomarkers, Telemedicine Tools

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19397&type=smp

Which Areas Are Leading Regions in the Digital Biomarkers Market Expansion Across the Globe?

North America was the largest region in the digital biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing the Digital Biomarkers Industry Evolution?

Prominent firms in the digital biomarker market are utilizing strategic alliances to broaden their scope and enrich their services. A strategic partnership commonly denotes a cooperative link between two or more entities wherein they amalgamate their strengths, competencies, and endeavors to meet shared goals or objectives. For example, ProofPilot, an American clinical trial automation provider, entered into a strategic alliance with Eli Lilly and Company, an American pharmaceutical firm, in September 2023. The alliance allowed for the incorporation of Lilly’s inventive, awaiting-patent sensor cloud infrastructure, Magnol.AI, into ProofPilot’s tech suite. Designed for exceptional security and convenience, Magnol.AI is a state-of-the-art platform that manages high-frequency sensor data. The chief aim of this merger is to improve the conduct quality of digital health research and to speed up non-competitive biomedical studies. By integrating this innovative platform, researchers are now able to make use of real-time data science features and obtain profound insights from sensor data. This ingenuity corresponds with clinician and patient-reported outcomes, paving the way for advancements in digital health and biomarker research.

View the full report here:

https://www.thebusinessresearchcompany.com/report/digital-biomarkers-global-market-report

How Is the Digital Biomarkers Market Conceptually Defined?

Digital biomarkers are objective, quantifiable physiological and behavioral data that are collected and measured using digital devices such as wearables, sensors, and mobile health applications. They are used to monitor and predict health outcomes, enabling more precise and personalized medical interventions. These biomarkers enable continuous and real-time health monitoring, leading to more personalized medical interventions and improved disease management.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19397

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model